Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142211 |
| CAS No | NA |
| Mol.F. | C18H20N4O2 |
| Mol.Wt. | 324.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142212 |
| CAS No | NA |
| Mol.F. | C18H18N4O3 |
| Mol.Wt. | 338.37 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142213 |
| CAS No | NA |
| Mol.F. | C19H22N4O3 |
| Mol.Wt. | 354.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142214 |
| CAS No | NA |
| Mol.F. | C19H18N4O3 |
| Mol.Wt. | 350.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142215 |
| CAS No | NA |
| Mol.F. | C17H20N4O2 |
| Mol.Wt. | 312.37 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0142216 |
| CAS No | NA |
| Mol.F. | C7H15N3O3S |
| Mol.Wt. | 221.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142217 |
| CAS No | NA |
| Mol.F. | C16H23N3O3 |
| Mol.Wt. | 305.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142218 |
| CAS No | NA |
| Mol.F. | C18H27N7O3 |
| Mol.Wt. | 389.46 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142219 |
| CAS No | NA |
| Mol.F. | C9H17N3O3 |
| Mol.Wt. | 215.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142220 |
| CAS No | NA |
| Mol.F. | C19H26N6O5 |
| Mol.Wt. | 418.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142221 |
| CAS No | NA |
| Mol.F. | C24H29N9O5 |
| Mol.Wt. | 523.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142222 |
| CAS No | NA |
| Mol.F. | C18H24N6O5 |
| Mol.Wt. | 404.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142223 |
| CAS No | NA |
| Mol.F. | C28H38N10O5 |
| Mol.Wt. | 594.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142224 |
| CAS No | NA |
| Mol.F. | C11H13N5O3 |
| Mol.Wt. | 263.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142225 |
| CAS No | NA |
| Mol.F. | C18H20N6O5 |
| Mol.Wt. | 400.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142226 |
| CAS No | NA |
| Mol.F. | C13H18N6O3 |
| Mol.Wt. | 306.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |